CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer

World Journal of Gastroenterology

Volumn 21, Issue 27, 2015, Pages 8238-8248

  Bordonaro, Michael ^a   Lazarova, Darina L ^a  

^a Janet Weis Children s Hospital   (United States)

Author keywords

Butyrate; Colorectal cancer; CREB binding protein; P300; Stem cells; Wnt

Indexed keywords

BETA CATENIN; BUTYRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; HISTONE DEACETYLASE INHIBITOR; N BENZYL 1,2,3,4,8,9 HEXAHYDRO 6 (4 HYDROXYBENZYL) 8 (1 NAPHTHYLMETHYL) 4,7 DIOXO 2H PYRAZINO[1,2 A]PYRIMIDINE 1(6H) CARBOXAMIDE; WNT PROTEIN; ANTINEOPLASTIC AGENT; BUTYRIC ACID DERIVATIVE; CREBBP PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CELL COUNT; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLORECTAL CANCER; DIETARY FIBER; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE MUTATION; HIGH FIBER DIET; HUMAN; MICROSATELLITE INSTABILITY; NONHUMAN; PROMOTER REGION; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY; ANIMAL; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUTYRATES; COLORECTAL NEOPLASMS; CREB-BINDING PROTEIN; DRUG RESISTANCE, NEOPLASM; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASE INHIBITORS; HUMANS; MOLECULAR TARGETED THERAPY; P300-CBP TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84938149540     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i27.8238     Document Type: Article

References (57)

1. Lazarova DL, Bordonaro M, Carbone R, Sartorelli AC. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer 2004; 110: 523-531 [PMID: 15122584 DOI: 10.1002/ijc.20152]
2. Bordonaro M, Lazarova DL, Sartorelli AC. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res 2007; 313: 1652-1666 [PMID: 17359971 DOI: 10.1016/j.yexcr.2007.02.008]
3. Richter M, Jurek D, Wrba F, Kaserer K, Wurzer G, Karner-Hanusch J, Marian B. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer 2002; 38: 1937-1945 [PMID: 12204677 DOI: 10.1016/S0959-8049(02]00158-2]
4. Kautenburger T, Beyer-Sehlmeyer G, Festag G, Haag N, Kühler S, Küchler A, Weise A, Marian B, Peters WH, Liehr T, Claussen U, Pool-Zobel BL. The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells. J Cancer Res Clin Oncol 2005; 131: 692-700 [PMID: 16133571 DOI: 10.1007/s00432-005-0013-4]
5. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744-749 [PMID: 16148886 DOI: 10.1038/nrc1694]
6. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjønneland A, Overvad K, Martinez C, Dorronsoro M, Gonzalez CA, Key TJ, Trichopoulou A, Naska A, Vineis P, Tumino R, Krogh V, Buenode-Mesquita HB, Peeters PH, Berglund G, Hallmans G, Lund E, Skeie G, Kaaks R, Riboli E. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361: 1496-1501 [PMID: 12737858 DOI: 10.1016/S0140-6736(03]13174-1]
7. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003; 361: 1491-1495 [PMID: 12737857 DOI: 10.1016/S0140-6736(03]13173-X]
8. Bingham SA, Norat T, Moskal A, Ferrari P, Slimani N, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjønneland A, Overvad K, Martinez C, Dorronsoro M, González CA, Ardanaz E, Navarro C, Quirós JR, Key TJ, Day NE, Trichopoulou A, Naska A, Krogh V, Tumino R, Palli D, Panico S, Vineis P, Bueno-de-Mesquita HB, Ocké MC, Peeters PH, Berglund G, Hallmans G, Lund E, Skeie G, Kaaks R, Riboli E. Is the association with fiber from foods in colorectal cancer confounded by folate intake? Cancer Epidemiol Biomarkers Prev 2005; 14: 1552-1556 [PMID: 15941971 DOI: 10.1158/1055-9965.EPI-04-0891]
9. Bingham SA. Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer. Proc Nutr Soc 1990; 49: 153-171 [PMID: 2172992 DOI: 10.1079/PNS19900021]
10. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-1227 [PMID: 3678950 DOI: 10.1136/gut.28.10.1221]
11. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 1992; 52: 5906-5912 [PMID: 1327519]
12. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 1994; 54: 3288-3293 [PMID: 8205551]
13. Hague A, Elder DJ, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995; 60: 400-406 [PMID: 7829251 DOI: 10.1002/ijc.2910600322]
14. Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 1997; 57: 3697-3707 [PMID: 9288776]
15. Marks PA, Dokmanovic M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin Investig Drugs 2005; 14: 1497-1511 [PMID: 16307490 DOI: 10.1517/13543784.14.12.1497]
16. Lin HY, Chen CS, Lin SP, Weng JR, Chen CS. Targeting histone deacetylase in cancer therapy. Med Res Rev 2006; 26: 397-413 [PMID: 16450343 DOI: 10.1002/med.20056]
17. Bordonaro M, Mariadason JM, Aslam F, Heerdt BG, Augenlicht LH. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ 1999; 10: 713-720 [PMID: 10547075]
18. Liu C, Zhang Y, Li J, Wang Y, Ren F, Zhou Y, Wu Y, Feng Y, Zhou Y, Su F, Jia B, Wang D, Chang Z. p15RS/RPRD1A (p15INK4b-related sequence/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt/β-catenin signaling pathway. J Biol Chem 2015; 290: 9701-9713 [PMID: 25697359 DOI: 10.1074/jbc.M114.620872]
19. Cook D, Fry MJ, Hughes K, Sumathipala R, Woodgett JR, Dale TC. Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J 1996; 15: 4526-4536 [PMID: 8887544]
20. Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P. Association of the APC gene product with beta-catenin. Science 1993; 262: 1731-1734 [PMID: 8259518 DOI: 10.1126/science.8259518]
21. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-1737 [PMID: 8259519 DOI: 10.1126/science.8259519]
22. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995; 92: 3046-3050 [PMID: 7708772 DOI: 10.1073/pnas.92.7.3046]
23. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-642 [PMID: 8757136 DOI: 10.1038/382638a0]
24. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destrée O, Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86: 391-399 [PMID: 8756721 DOI: 10.1016/S0092-8674(00]80112-9]
25. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-1787 [PMID: 9065401 DOI: 10.1126/science.275.5307.1784]
26. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-1790 [PMID: 9065402 DOI: 10.1126/science.275.5307.1787]
27. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320 [PMID: 11057903 DOI: 10.1016/S0092-8674(00]00122-7]
28. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, Leitão CN, Fodde R, Smits R. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 2002; 11: 1549-1560 [PMID: 12045208 DOI: 10.1093/hmg/11.13.1549]
29. Bordonaro M, Lazarova DL, Sartorelli AC. Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer? Oncol Res 2008; 17: 1-9 [PMID: 18488710]
30. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, Ha JR, Kahn M. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA 2004; 101: 12682-12687 [PMID: 15314234 DOI: 10.1073/pnas.0404875101]
31. Lenz HJ, Kahn M. Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci 2014; 105: 1087-1092 [PMID: 24975284 DOI: 10.1111/cas.12471]
32. Teo JL, Ma H, Nguyen C, Lam C, Kahn M. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. Proc Natl Acad Sci USA 2005; 102: 12171-12176 [PMID: 16093313 DOI: 10.1073/pnas.0504600102]
33. Ma H, Nguyen C, Lee KS, Kahn M. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 2005; 24: 3619-3631 [PMID: 15782138 DOI: 10.1038/sj.onc.1208433]
34. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, Kahn M. Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci USA 2007; 104: 5668-5673 [PMID: 17372190 DOI: 10.1073/pnas.0701331104]
35. Teo JL, Kahn M. The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators. Adv Drug Deliv Rev 2010; 62: 1149-1155 [PMID: 20920541 DOI: 10.1016/j.addr.2010.09.012]
36. Waltzer L, Bienz M. Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature 1998; 395: 521-525 [PMID: 9774110 DOI: 10.1038/26785]
37. Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J 2000; 19: 1839-1850 [PMID: 10775268 DOI: 10.1093/emboj/19.8.1839]
38. Li J, Sutter C, Parker DS, Blauwkamp T, Fang M, Cadigan KM. CBP/p300 are bimodal regulators of Wnt signaling. EMBO J 2007; 26: 2284-2294 [PMID: 17410209 DOI: 10.1038/sj.emboj.7601667]
39. Lévy L, Wei Y, Labalette C, Wu Y, Renard CA, Buendia MA, Neuveut C. Acetylation of beta-catenin by p300 regulates betacatenin-Tcf4 interaction. Mol Cell Biol 2004; 24: 3404-3414 [PMID: 15060161 DOI: 10.1128/MCB.24.8.3404-3414.2004]
40. Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 2010; 16: 3153-3162 [PMID: 20530697 DOI: 10.1158/1078-0432.CCR-09-2943]
41. Lazarova DL, Chiaro C, Wong T, Drago E, Rainey A, O'Malley S, Bordonaro M. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells. J Cancer 2013; 4: 481-490 [PMID: 23901348 DOI: 10.7150/jca.6583]
42. Lazarova DL, Wong T, Chiaro C, Drago E, Bordonaro M. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells. J Cancer 2013; 4: 491-501 [PMID: 23901349 DOI: 10.7150/jca.6582]
43. Lazarova D, Lee A, Wong T, Marian B, Chiaro C, Rainey C, Bordonaro M. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells. J Cancer 2014; 5: 203-213 [PMID: 24563675 DOI: 10.7150/jca.8569]
44. Grigson ER, Ozerova M, Pisklakova A, Liu H, Sullivan DM, Nefedova Y. Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner. PLoS One 2015; 10: e0117693 [PMID: 25635944 DOI: 10.1371/journal.pone.0117693]
45. Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19: 150-158 [PMID: 17306971 DOI: 10.1016/j.ceb.2007.02.007]
46. Huh JW, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Chun HK. Prognostic impact of p300 expression in patients with colorectal cancer. J Surg Oncol 2013; 108: 374-377 [PMID: 24142575 DOI: 10.1002/jso.23405]
47. Jia Y, Nie F, Du A, Chen Z, Qin Y, Huang T, Song X, Li L. Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. J Mol Cell Biol 2014; 6: 231-239 [PMID: 24748645 DOI: 10.1093/jmcb/mju014]
48. Götze S, Coersmeyer M, Müller O, Sievers S. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells. Int J Oncol 2014; 45: 1715-1723 [PMID: 25050608 DOI: 10.3892/ijo.2014.25]
49. Chiaro C, Lazarova DL, Bordonaro M. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells. Biochem Biophys Res Commun 2012; 428: 121-126 [PMID: 23063976 DOI: 10.1016/j.bbrc.2012.10.018]
50. Kida A, Kahn M. Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcription. Curr Mol Pharmacol 2013; 6: 204-210 [PMID: 24720539]
51. Hao J, Ao A, Zhou L, Murphy CK, Frist AY, Keel JJ, Thorne CA, Kim K, Lee E, Hong CC. Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen. Cell Rep 2013; 4: 898-904 [PMID: 24012757 DOI: 10.1016/j.celrep.2013.07.047]
52. Bordonaro M, Tewari S, Cicco CE, Atamna W, Lazarova DL. A switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cells. PLoS One 2011; 6: e27308 [PMID: 22073312 DOI: 10.1371/journal.pone.0027308]
53. Lazarova DL, Bordonaro M. Extreme fluctuations in Wnt/betacatenin signaling as an approach for colon cancer prevention and therapy. Adv Stud Biol 2012; 4: 351-362
54. Ionov Y, Matsui S, Cowell JK. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA 2004; 101: 1273-1278 [PMID: 14732695 DOI: 10.10173/pnas.0307276101]
55. Woerner SM, Tosti E, Yuan YP, Kloor M, Bork P, Edelmann W, Gebert J. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors. Mol Carcinog 2014; Epub ahead of print [PMID: 25213383 DOI: 10.1002/mc.22213]
56. Arensman MD, Telesca D, Lay AR, Kershaw KM, Wu N, Donahue TR, Dawson DW. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol Cancer Ther 2014; 13: 2303-2314 [PMID: 25082960 DOI: 10.1158/1535-7163.MCT-13-1005]
57. Sasaki T, Kahn M. Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epithelium. Transl Respir Med 2014; 2: 8 [PMID: 25505699 DOI: 10.1186/s40247-014-0008]